Yun Zhong
Stock Analyst at Wedbush
(0.08)
# 4,715
Out of 5,023 analysts
449
Total ratings
37.4%
Success rate
-9.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGMT Sagimet Biosciences | Reiterated: Buy | $28 | $9.14 | +206.35% | 13 | Oct 1, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Buy | $35 | $17.50 | +100.00% | 33 | Sep 30, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $12 | $3.78 | +217.46% | 23 | Sep 30, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $8 | $4.00 | +100.00% | 10 | Sep 29, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $6 | $4.01 | +49.63% | 25 | Sep 25, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $327 | $227.87 | +43.50% | 33 | Sep 16, 2026 | |
| BNTC Benitec Biopharma | Reiterated: Buy | $16 → $17 | $8.98 | +89.31% | 2 | Sep 15, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Buy | $15 | $2.56 | +485.94% | 24 | Sep 15, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 → $13 | $4.58 | +183.84% | 12 | Sep 9, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $173 | $140.06 | +23.52% | 30 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 | $57.18 | +64.39% | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 | $2.70 | +529.63% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $11.41 | +197.98% | 22 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.45 | +226.53% | 25 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.80 | +110.53% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $11.36 | +40.85% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $8 | $4.13 | +93.70% | 24 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $1.82 | n/a | 15 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.63 | n/a | 14 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $38 | $23.46 | n/a | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $22.54 | n/a | 13 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.58 | n/a | 7 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.3798 | n/a | 9 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $7.36 | n/a | 13 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $88.21 | n/a | 9 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.05 | n/a | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $15.51 | n/a | 2 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $20.00 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.76 | n/a | 3 | Jun 28, 2018 |
Sagimet Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: $28
Current: $9.14
Upside: +206.35%
Sarepta Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $35
Current: $17.50
Upside: +100.00%
Wave Life Sciences
Sep 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.78
Upside: +217.46%
Camp4 Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $8
Current: $4.00
Upside: +100.00%
Rezolute
Sep 25, 2026
Reiterated: Buy
Price Target: $6
Current: $4.01
Upside: +49.63%
Ascendis Pharma
Sep 16, 2026
Reiterated: Buy
Price Target: $327
Current: $227.87
Upside: +43.50%
Benitec Biopharma
Sep 15, 2026
Reiterated: Buy
Price Target: $16 → $17
Current: $8.98
Upside: +89.31%
Rocket Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: $15
Current: $2.56
Upside: +485.94%
Opus Genetics
Sep 9, 2026
Reiterated: Buy
Price Target: $10 → $13
Current: $4.58
Upside: +183.84%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $173
Current: $140.06
Upside: +23.52%
Aug 18, 2026
Reiterated: Buy
Price Target: $94
Current: $57.18
Upside: +64.39%
Aug 11, 2026
Rated: Buy
Price Target: $17
Current: $2.70
Upside: +529.63%
Aug 10, 2026
Reiterated: Buy
Price Target: $34
Current: $11.41
Upside: +197.98%
Aug 7, 2026
Reiterated: Buy
Price Target: $8
Current: $2.45
Upside: +226.53%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $3.80
Upside: +110.53%
Aug 4, 2026
Reiterated: Hold
Price Target: $16
Current: $11.36
Upside: +40.85%
Apr 21, 2026
Downgraded: Hold
Price Target: $8
Current: $4.13
Upside: +93.70%
Mar 30, 2023
Rated: Buy
Price Target: $28
Current: $1.82
Upside: n/a
Mar 30, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.63
Upside: n/a
Mar 28, 2023
Rated: Buy
Price Target: $38
Current: $23.46
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $4
Current: $22.54
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $3.58
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $4
Current: $0.3798
Upside: n/a
Mar 21, 2023
Reiterated: Buy
Price Target: $8
Current: $7.36
Upside: n/a
Jan 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $88.21
Upside: n/a
May 12, 2020
Reiterated: Buy
Price Target: $10
Current: $1.05
Upside: n/a
Feb 4, 2020
Reiterated: Buy
Price Target: $14
Current: $15.51
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $20.00
Upside: n/a
Jun 28, 2018
Downgraded: Hold
Price Target: n/a
Current: $16.76
Upside: n/a